Journal
VACCINE
Volume 28, Issue 46, Pages 7345-7350Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.09.005
Keywords
Venezuelan equine encephalitis virus; (VEEV); DNA vaccine; Nonhuman primates; Aerosol challenge
Categories
Funding
- Defense Threat Reduction Agency (DTRA) [H H 0001_07_RD_B]
Ask authors/readers for more resources
A study to evaluate the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus (VEEV) DNA vaccine in an aerosol model of nonhuman primate infection was performed Cynomolgus macaques vaccinated with a plasmid expressing the 26S structural genes of VEEV subtype IAB by particle-mediated epidermal delivery (PMED) developed virus-neutralizing antibodies No serum viremia was detected in two out of three macaques vaccinated with the VEEV DNA after aerosol challenge with homologous virus while one displayed a low viremia on a single day postchallenge In contrast all three macaques vaccinated with empty vector DNA developed a high viremia that persisted for at least 3 days after challenge In addition macaques vaccinated with the VEEV DNA had reduced febrile reactions lymphopenia and clinical signs of disease postchallenge as compared to negative control macaques Therefore although the sample size was small in this pilot study these results indicate that a VEEV DNA vaccine administered by PMED can at least partially protect nonhuman primates against an aerosol VEEV challenge (C) 2010 Elsevier Ltd All rights reserved
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available